LEGEND BIOTECH CORP-ADR (LEGN)

US52490G1022 - ADR

45.3  +0.88 (+1.98%)

After market: 45.3 0 (0%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
68.8M
-8.27%		117M
70.06%		285.143M
143.71%		609.28M
113.68%
EBITDA
YoY % growth
-380.1M
-26.74%		-439.7M
-15.68%		-421.765M
4.08%		-322.218M
23.60%		N/AN/AN/AN/A
EBIT
YoY % growth
-394M
-27.18%		-458.1M
-16.27%		-442.216M
3.47%		-360.311M
18.52%
Operating Margin
-572.67%-391.54%-155.09%-59.14%
EPS
YoY % growth
-1.35N/A-2.96-1.51
49.07%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q1 / 24 Q2 / 24 Q3 / 24 Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth		-0.35
48.36%
Revenue
Q2Q % growth		156.43M
330.46%		N/AN/AN/AN/A
EBITDA
Q2Q % growth		-73.44MN/AN/AN/AN/A
EBIT
Q2Q % growth		-72.333M
41.82%		N/AN/AN/AN/A

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth		 -0.80 -0.850.055.50%
Q3 2023
Q2Q % growth		 -0.34 -0.690.3550.80%
Q2 2023
Q2Q % growth		 -1.14
8.06%		-0.61-0.53-86.27%
Q1 2023
Q2Q % growth		 -0.68
-161.54%		-0.800.1214.53%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth		 79.464M
-32.08%		88.08M-8.616M-9.78%
Q3 2023
Q2Q % growth		 96.01M 99.229M-3.219M-3.24%
Q2 2023
Q2Q % growth		 73.33M
512.61%		55.71M17.62M31.63%
Q1 2023
Q2Q % growth		 36.34M
-27.38%		40.622M-4.282M-10.54%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS-7.59% 44.91% 30.94% 20.43%
Revenue-11.63% -9.74% 2.81% -0.19%